首页 | 本学科首页   官方微博 | 高级检索  
     


A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma
Authors:Andrew W. Hahn  Charles Drake  Samuel R. Denmeade  Yousef Zakharia  Benjamin L. Maughan  Eugene Kennedy  Charles Link Jr.  Nicholas Vahanian  Hans Hammers  Neeraj Agarwal
Affiliation:1. Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA;2. Divison of Hematology/Oncology, Department of Medicine, New York Presbyterian, Columbia University Medical Center, New York, New York, USA;3. Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA;4. Division of Hematology, Oncology, and Blood and Marrow Transplant, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA;5. NewLink Genetics Corporation, Ames, Iowa, USA;6. Division of Hematology/Oncology, Department of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号